Understanding Endometrial Cancer Patient Engagement in Clinical Trials
This study is looking at the experiences of people with endometrial cancer who are already taking part in a separate clinical trial that involves a specific medication. The main goal is to understand how many patients decide to join these trials and how many stay in them until the end. Researchers will measure how many patients enroll in a clinical trial within 3 months and how many complete it over 12 months. You can join if you have been diagnosed with endometrial cancer, are 18 or older, and are able to follow the study's instructions. This study is currently unclear about its recruitment status. The information gathered will help improve future care for all endometrial cancer patients, especially those from under-represented groups.
- Study design
- This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It aims to include 500 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track how many patients enroll in a clinical trial at 3 months and how many complete it at 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Revealing Engagement Patterns Among Endometrial Cancer Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael B Gill · STUDY_DIRECTOR · Power Life Sciences Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of patients who decide to enroll in an endometrial cancer clinical research3 months
- Rate of patients who remain in an endometrial cancer clinical trial to trial completion12 months